| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $10.5M | +19.6% |
| Cost of Revenue | $3.4M | +15.9% |
| Gross Profit | $7.1M | +21.4% |
| R&D Expense | $3.5M | -35.9% |
| SG&A Expense | $3.6M | -15.3% |
| Operating Income | -$2.7M | +58.6% |
| Pre-tax Income | -$2.6M | +60.1% |
| Net Income | -$2.6M | +60.1% |
| EPS (Basic) | -$0.13 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.8M | +269.7% |
| Accounts Receivable | $841K | +16.3% |
| Current Assets | $8.2M | +132.2% |
| Total Assets | $19.3M | +23.9% |
| Current Liabilities | $2.3M | -3.7% |
| Total Liabilities | $2.3M | -41.7% |
| Stockholders' Equity | $16.9M | +46.8% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$274K | +94.7% |
| Capital Expenditures | $43K | +34.7% |
| Investing Cash Flow | -$1.5M | -0.9% |
| Financing Cash Flow | $6.8M | +129.1% |
| Free Cash Flow | -$316K | +94.0% |
| +65.8% |
| EPS (Diluted) | -$0.13 | +65.8% |